LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

Inicio・Lista de Acciones・Amicus Therapeutics Inc

Amicus Therapeutics Inc

Cerrado

SectorSalud

9.81 -0.2

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

9.79

Máximo

9.92

Métricas clave
By Trading Economics
Ingresos	42M 17M
Ventas	14M 169M
BPA	0.17
Margen de beneficio	10.237
Empleados	499
EBITDA	54M 48M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+61.22% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	678M 3B
Apertura anterior	10.01
Cierre anterior	9.81

Noticias sobre sentimiento de mercado

By Acuity

39%

61%

128 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

5.925 / 7.38 Soporte y Resistencia

Amicus Therapeutics Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

8 dic 2025, 23:48 UTC

Principales Movimientos del Mercado

Shares of Sezzle and Vital Farms Rise on S&P SmallCap 600 Inclusion

8 dic 2025, 23:44 UTC

Charlas de Mercado

Perky Australian Dollar Looks to Extend Gains -- Market Talk

8 dic 2025, 23:42 UTC

Charlas de Mercado

Nikkei May Decline Amid Uncertainty Over Econ, Earnings -- Market Talk

8 dic 2025, 23:13 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

8 dic 2025, 23:13 UTC

Charlas de Mercado

Australian Inflation Expectations Highest Since Late 2023 -- Market Talk

8 dic 2025, 23:09 UTC

Adquisiciones, fusiones, absorciones

Paramount Made a Hostile Bid for Warner After Netflix Deal. What Happens Next? -- WSJ

8 dic 2025, 22:46 UTC

Charlas de Mercado

Rio Tinto Building Low-Cost Lithium Business in Difficult Market -- Market Talk

8 dic 2025, 22:01 UTC

Charlas de Mercado

Miners Poised to Do Well in 2026 -- Market Talk

8 dic 2025, 22:00 UTC

Adquisiciones, fusiones, absorciones

Noble: Agreement With Borr Includes Sale of Noble Tom Prosser, Noble Mick O'Brien, Noble Regina Allen, Noble Resilient, Noble Resolute, Closing Expected in Early 2026 >NE

8 dic 2025, 22:00 UTC

Adquisiciones, fusiones, absorciones

Noble: Agreement With Borr Comprises $210M in Cash and $150M in Seller Notes >NE

8 dic 2025, 22:00 UTC

Adquisiciones, fusiones, absorciones

Noble: Agreement With Ocean Oilfield Drilling Anticipates the Sale of the Noble Resolve, Closing Is Expected in 2Q 2026, Upon Conclusion of Noble Resolve's Current Contract >NE

8 dic 2025, 22:00 UTC

Adquisiciones, fusiones, absorciones

Noble: To Sell Five Rigs to Borr Drilling Limited for $360M and One Rig to Ocean Oilfield Drilling for $64M in Cash >NE

8 dic 2025, 21:51 UTC

Charlas de Mercado

US-Canada Rate Spreads Narrow Sharply After Record Gap -- Market Talk

8 dic 2025, 21:50 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

8 dic 2025, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

8 dic 2025, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

8 dic 2025, 21:38 UTC

Adquisiciones, fusiones, absorciones

Boeing Buys Company Responsible for Door Blowout. The Stock Rises. -- Barrons.com

8 dic 2025, 21:38 UTC

Adquisiciones, fusiones, absorciones

Paramount Makes $77.9 Billion Hostile Bid for Warner After Netflix Struck Deal -- 7th Update

8 dic 2025, 21:36 UTC

Charlas de Mercado

Oil Oversupply to Show Up As Waterborne Stocks Land -- Market Talk

8 dic 2025, 21:20 UTC

Adquisiciones, fusiones, absorciones

Will the Netflix-Warner Bros. Merger Go Through? It Depends on How You Define Market Share. -- Barrons.com

8 dic 2025, 21:12 UTC

Adquisiciones, fusiones, absorciones

These Stocks Moved the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8 dic 2025, 21:08 UTC

Charlas de Mercado

Rosenberg Turns 'Outright Bullish' on Canada Dollar -- Market Talk

8 dic 2025, 20:38 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Netflix Co-CEOs Confident About Regulatory Approval for WBD Deal -- Market Talk

8 dic 2025, 20:26 UTC

Adquisiciones, fusiones, absorciones

These Stocks Are Moving the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8 dic 2025, 20:18 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Netflix Isn't Looking to Make Cuts at Warner Bros. Discovery -- Market Talk

8 dic 2025, 20:07 UTC

Charlas de Mercado

Oil Futures Snap Three-Session Winning Streak -- Market Talk

8 dic 2025, 20:06 UTC

Charlas de Mercado

U.S. Natural Gas Pulls Back From Weather-Driven Highs -- Market Talk

8 dic 2025, 20:05 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

8 dic 2025, 20:05 UTC

Charlas de Mercado

Deere Offers Sales Growth Forecast Through 2030 -- Market Talk

8 dic 2025, 20:01 UTC

Charlas de Mercado

Precious Metals Slip Ahead of Fed Decision -- Market Talk

Comparación entre iguales

Cambio de precio

Amicus Therapeutics Inc Esperado

Precio Objetivo

By TipRanks

61.22% repunte

Estimación a 12 meses

Media 15.88 USD 61.22%

Máximo 21 USD

Mínimo 11 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Amicus Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

8 ratings

Comprar

Mantener

Vender

De acuerdo con 8 analistas que ofrecen calificaciones bursátiles a para Amicus Therapeutics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

5.925 / 7.38Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentimiento

By Acuity

128 / 374 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Amicus Therapeutics Inc

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, for the treatment of late onset. It has collaboration and license agreements with the University of Pennsylvania to research and develop parvovirus gene therapy products; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.